Safety and Tolerability in Healthy Volunteers — A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
Citation(s)
A Phase 1, Single- and Multiple-Dose, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating Study to Assess the Safety, Tolerability, and Pharmacokinetics of NLY01 in Healthy Subjects